The Academy of Pharmaceutical Sciences

Bear Sighted in Northern End of Lawrence Township

Editor's Note: The following advisory was issued today by the Lawrence Township Health Department.

Ambit Biosciences and Teva Announce Clearance of an Investigational...

Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug Application for CEP-32496, A Novel BRAF Inhibitor SAN DIEGO and JERUSALEM, May 17, 2012 /PRNewswire/ -- Ambit Biosciences and Teva Pharmaceutical Industries Limited today announced the clearance of an Investigational New Drug application with the U.S. Food and Drug ... (more)

Mylan to market generic Plavix

Mylan Pharmaceuticals, a unit of Southpointe-based Mylan Inc. received approval for Clopidogrel Tablets USP, 75 mg and 300 mg.

New Competitive Arena Emerges for Pharmaceutical Companies in...

NEW YORK, May 17, 2012 /PRNewswire/ -- Pharmaceutical companies that are first to meet healthcare's new expectations of value could have an advantage in the competition for market share and brand differentiation, according to a report published today by the Health Research Institute at PwC US.

Therapeutic Supply Chain

At the heart of Marken's therapeutic supply chain is a network of strategically located, purpose-built depots.

Lobbying group for pharma companies says U.S. risks losing research jobs to other countries

Other countries are aggressively wooing researchers and the resources of major U.S. pharmaceutical companies, according to the industry's leading trade group.

Republicans say they'll publicize pharma industry's Obamacare deal

House Republicans on Wednesday said they will provide more details on the pharmaceutical industry's deal to support President Obama's landmark health law.

Big Pharma Bands with Academia in $23-Million Deal

News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts.

JP Morgan, Morgan Stanley, BofA Merrill Lynch run Cardinal Health USD500m debt issue

One of the batches consists of notes bearing a 1.9% coupon and maturing on 15 June 2017, whereas the other one is comprised of notes carrying a coupon of 3.2% and falling due on 15 June 2022.

Cardinal, DEA settle Florida shipping case

Online? On the go? An exact replica of The Dispatch, the E-Edition is available 24/7 on your PC or iPAD.

Joint working - a quick start reference guide for NHS and pharmaceutical industry partners

Produced by The King's Fund Information & Library Service, this current awareness service brings together the latest policy, guidance, research and reports related to health management and commissioning.

In search of sustainability: process R&D in light of current pharmaceutical industry challenges

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

Health-care Stocks: Cardinal Health settles Florida DEA charges

Cardinal Health Inc. said Tuesday it has settled charges by the Drug Enforcement Administration that the company improperly controlled the distribution of pain medication at a Florida facility.

US consumers hold back, even as gas prices fall

Pharmaceutical wholesaler Cardinal Health Inc. says one of its Florida facilities will suspend shipments of controlled substances for two years under a settlement with federal authorities over alleged ineffective controls.

Cardinal Health settles Florida DEA charges

Cardinal Health Inc. said Tuesday it has settled charges by the Drug Enforcement Administration that the company improperly controlled the distribution of pain pills at a Florida facility.

Patient Safety Technologies: The Next Standard Of Care

Did you know that on average, a surgical sponge is retained in one out of every 8000 surgeries here in the U.S? That amounts to 4000 incidents per year, or 11 per day.

Cardinal Health ends DEA inquiry with settlement

Pharmaceutical wholesaler Cardinal Health Inc. said Tuesday one of its Florida facilities will be barred from shipping controlled substances for two years under a settlement with federal authorities over alleged ineffective controls.

Developments in British phone-hacking scandal

By The Associated Press Developments in a phone-hacking scandal involving British newspapers owned by Rupert Murdoch's News Corp.: By The Associated Press Developments in a phone-hacking scandal involving British newspapers owned by Rupert Murdoch's News Corp.: Saks reported a 13 percent bump in first-quarter profit, but weak demand of women's ... (more)

Wolters Kluwer Sells Its Healthcare Analytics Business to Symphony Technology Group

CEO and Chairman of the Executive Board of Wolters Kluwer Nancy McKinstry has said that "the sale of our pharma-related business is part of our strategy to focus on our core health markets and accelerate growth by providing innovative solutions to clinicians globally." "After conducting a thorough process, the sale to STG is a perfect fit for ... (more)

Bristol-Myers Squibb and Tsinghua University Enter Strategic Partnership

Bristol-Myers Squibb Company and Tsinghua University of Beijing, China, today announced the formation of a multi-year strategic partnership.

Mylan Launches Generic LipitorA In Five European Countries

Pittsburgh, PA, LYON, France /PRNewswire/ -- Mylan Inc. today announced that it has launched Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg in France, Belgium, the UK, the Netherlands and Ireland.

Pledges to drugs discovery centre take investment to A 50m level

Six of the world's largest drug companies today announced a 14.4 million injection to fund research in Dundee that will develop treatments for diseases such as arthritis, cancer and Parkinson's. The funding boost will secure 50 posts for the next four years at the Division of Signal Transduction Therapy , which is described as a unique ... (more)

Stock Insights: American Public Education, Agilent Technologies, Boeing , Nuance, Mylan May 11th

Boeing Co. : Sterne Agee expects Boeing's Investor Day to be positive for the stock, as the firm thinks the company is making significant progress on its new programs.

Pfizer Set To Surge On 3 New Drug Candidates

Lipitor , marketed by Pfizer to reduce blood cholesterol levels, has been the best-selling pharmaceutical of all time, with aggregate sales of over $125 billion and still going.

Mylan Raises 2012 Earnings Guidance - Analyst Blog

MYL ) recently announced that it expects 2012 adjusted earnings in the range of $2.45 to $2.55 per share, up from the previously guided range of $2.30 to $2.50 per share.

Top-line results from Takeda vedolizumab phase 3 trial on Crohn's disease

Takeda Pharmaceutical Company Limited today announced top-line results from the international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase 3 trial.

Mylan Launches Generic LipitorA in Five European Countries

PITTSBURGH and LYON, France, May 11, 2012 /PRNewswire/ -- Mylan Inc. today announced that it has launched Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg in France, Belgium, the UK, the Netherlands and Ireland.

Mylan (MYL) says it will launch sales of its generic version of...

Mylan says it will launch sales of its generic version of Lipitor in France, Belgium, the U.K., the Netherlands and Ireland after winning regulatory approvals in each country.

OncoMed files for $115 million IPO

The Redwood City-based cancer drug developer, one of the most successful Bay Area biotech companies at raising venture capital over the past five years, said it will use proceeds of the IPO to advance its lead drug -- demcizumab, or OMP-21M18 -- and two other drugs into Phase II clinical trials and for programs with partners GlaxoSmithKline and ... (more)

Mylan Given "Buy" Rating at Goldman Sachs

's stock had its "buy" rating reiterated by equities research analysts at Goldman Sachs in a research note issued to investors on Friday.

Teva Pharmaceutical Industries Ltd Downgraded by Needham & Company

Teva Pharmaceutical Industries Ltd opened at 42.19 on Thursday. Teva Pharmaceutical Industries Ltd has a 1-year low of $35.00 and a 1-year high of $51.15. The company has a market cap of $37.254 billion and a price-to-earnings ratio of 13.65. Teva Pharmaceutical Industries Ltd last released its earnings data on Wednesday, May 9th.

What is the Citizens Commission on Human Rights?

The Citizens Commission on Human Rights is a nonprofit mental health watchdog, responsible for helping to enact more than 150 laws protecting individuals from abusive or coercive practices.

Watson Has Double-Digit Upside, But Peers Are 'Strong Buys'

From high dividend yields to low betas, healthcare stocks are exceptionally safe.

Indian drugs to ruin Pak pharmaceutical industry, fear local manufacturers

Islamabad, May 10 : Pakistan's local pharmaceutical industry has demanded the government to allow only those imports from India, which are approved by the international drug regularity bodies.

Generic drugmaker Mylan raises 2012 profit outlook

Mylan Inc. raised its 2012 earnings forecast on Thursday, just a few weeks after the generic drugmaker reported a 24 percent increase in its first-quarter net income.

Watson seeks approval for generic ulcerative colitis drug

Generic drug maker Watson Pharmaceuticals is hoping to be the first to market a generic version of a drug used to treat ulcerative colitis, the company said.

Teva Pharmaceutical Industries Limited's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Ladies and, gentlemen, thank you for standing by. Welcome to the Teva Pharmaceutical Industries Ltd.

Dropped Direct

GLAXOSMITHKLINE fell 14p to 1410 as it took its A 1.6billion offer for biotech firm HUMAN GENOME SCIENCES direct to the US group's shareholders.

Teva Pharmaceutical Industries Limited Appoints as President of...

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Teva Pharmaceutical Industries Limited Appoints Michael Hayden as President of Global Research and Development and Chief Scientific Officer JERUSALEM-- --Teva Pharmaceutical ... (more)

Glaxo makes $2.6bn hostile bid for Human Genome

GLAXOSMITHKLINE has made a $2.6bn hostile takeover bid for Human Genome Sciences with a $13-a-share tender offer.

BASF Acquires Global Leader in Omega-3 Fatty Acids for the Pharmaceutical Industry

Ludwigshafen, Germany - May 9, 2012 - BASF today announced the acquisition of Equateq Ltd., a global leader in the manufacturing of highly concentrated omega-3 fatty acids.

5 Huge Reasons To Buy GlaxoSmithKline Now

The pharmaceutical industry has been outperforming the overall economy for quite some time now.

NSF-DBA Expands Pharmaceutical Services in India through...

DBA, an NSF International Health Sciences Company with more than 25 years of experience in the pharmaceutical industry, has signed a collaborative agreement with Semler Research Center Pvt Ltd.

Teva profit beats forecasts on U.S. drug sales

Teva Pharmaceutical Industries' Jerusalem oral solid dosage plant is seen December 21, 2011.

India Ranbaxy Q1 profit jumps on generic Lipitor

Ranbaxy Laboratories, India's top drugmaker by sales, reported a four-fold rise in quarterly net profit, helped by sales of its generic version of cholesterol drug Lipitor in its key U.S. market, sending its shares up more than 4.5 percent.